Sedov V M, Sedletskiĭ Iu I, Belianina E O
Vestn Khir Im I I Grek. 1999;158(5):53-6.
The authors have analyzed and generalized their 20-years experience with surgical treatment of 247 patients with recurrent goiter. Among them 48 patients had recurrent toxic goiter and 199 patients had nontoxic goiter. Postoperative complications developed in 8.3% of the patients with recurrent toxic goiter and in 6% of the patients with nontoxic goiter. The overall postoperative lethality was 1.2%. Operative treatment is recommended by the authors for recurrent toxic and nontoxic goiter, conservative treatment with radioactive iodine is thought to be expedient for a repeated recurrence. For preventing recurrences of toxic and nontoxic goiter after the first operation the administration of small does of the thyroid hormones is considered to be expedient during 1.5-2 months.
作者分析并总结了他们20年来对247例复发性甲状腺肿患者进行手术治疗的经验。其中48例为复发性毒性甲状腺肿,199例为非毒性甲状腺肿。复发性毒性甲状腺肿患者术后并发症发生率为8.3%,非毒性甲状腺肿患者为6%。术后总死亡率为1.2%。作者推荐对复发性毒性和非毒性甲状腺肿进行手术治疗,对于再次复发的情况,认为放射性碘保守治疗是合适的。为预防首次手术后毒性和非毒性甲状腺肿的复发,在1.5 - 2个月内给予小剂量甲状腺激素被认为是合适的。